Advertisement

Several Cytokines Do not Influence Activity of P210BCR-ABL Kinase in K562 Cells

  • A. Käbisch
  • T. Tamura
  • H. Pralle
Conference paper

Abstract

Chronic myelogenous leukemia (CML) is a disease which has, in its chronic phase, the dominant feature of a myeloproliferative disorder. It is characterized by the clonal expansion of a hematopoietic stem cell.

Keywords

Retinoic Acid K562 Cell Chronic Myelogenous Leukemia Tyrosine Kinase Activity Chronic Myelogenous Leukemia Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alitalo R (1987) The bcr-c-abl tyrosine kinase activity is extinguished by TPA in K562 leukemia cells. FEBS Lett 222:293–298PubMedCrossRefGoogle Scholar
  2. 2.
    Fraser JK, Lin F-K, Berridge MV (1988) Expression and modulation of specific high affinity binding sites for erythropoietin on the human erythroleukemia cell line K562. Blood 71:104–109PubMedGoogle Scholar
  3. 3.
    Ganser A. Völkers B, Scigalla P, Hoelzer D (1988) Effect of human recombinant erythropoietin on human hemopoietic progenitor cells in-vitro. Klin Wochenschr 66:236–240PubMedCrossRefGoogle Scholar
  4. 4.
    Harel-Bellan P, Farrar WC (1987) Modulation of protooncogene expression by colony stimulating factors. Biochem Biophys Res Commun 148:1001–1008PubMedCrossRefGoogle Scholar
  5. 5.
    Herrmann F, Mertelsmann R (1989) Polypeptides controlling hematopoietic cell development and activation. I. In vitro results. Blut 58:117–128Google Scholar
  6. 6.
    Lopez AF, TO LB, Yang Y-C et al. (1987) Stimulation of proliferation, differentiation, and function of human cells by primate interleukin-3. Proc Natl Acad Sci USA 84:2761–2765PubMedCrossRefGoogle Scholar
  7. 7.
    Lozzio CB, Lozzio BB (1975) Human chronic myelogenous cell line with positive Philadelphia-chromosome. Blood 45:321PubMedGoogle Scholar
  8. 8.
    Muncker R, DiPerio J, Koeffler HP (1987) Tumor necrosis factor:receptors on hematopoietic cells. Blood 70:1730–1734Google Scholar
  9. 9.
    Nishimura J, Takahira H, Shibata K et al. (1988) Regulation of biosynthesis and phosphorylation of P210bcr-abl protein during differentiation induction of K562 cells. Leuk Res 12:875–885PubMedCrossRefGoogle Scholar
  10. 10.
    Sieff CA, Tsai S, Faller DV (1987) Interleukin-1 induces cultured human endothelial cell production of granulocyte-macrophage colony stimulating factor. J Clin Invest 79:48–51PubMedCrossRefGoogle Scholar
  11. 11.
    Sieff CA (1987) Hematopoietic growth factors. J Clin Invest 79:1549–1557PubMedCrossRefGoogle Scholar
  12. 12.
    Young JC, Witte ON (1988) Selective transformation of primitive lymphoid cells by the BCR-ABL oncogene expressed in long term lymphoid or myeloid cultures. Mol Cell Biol 8:4049–4057Google Scholar
  13. 13.
    Laemmli, UK (1970), Cleavage of structurae proteins during the assembly of the head of bacteriophage T4 Nature 227, 680–685PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1990

Authors and Affiliations

  • A. Käbisch
  • T. Tamura
  • H. Pralle

There are no affiliations available

Personalised recommendations